Artwork
iconShare
 
Manage episode 519119135 series 3465164
Content provided by Rodney Moses. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rodney Moses or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a Message

Viral Thakkar, COO of LungPacer Medical, joins Rodney on the MedTech 101 Podcast to discuss how cutting-edge innovation is reshaping ventilator technology. They unpack the limitations of traditional mechanical ventilation and its often-overlooked effects on the diaphragm. Viral shares insights into AeroPace, LungPacer’s breakthrough system that uses phrenic nerve stimulation to help patients breathe and recover more effectively.
The discussion dives into the real-world challenges of clinical adoption, the significance of FDA Breakthrough Designation, and what the future holds for ventilation care. Tune in to learn how this technology could redefine outcomes for ICU patients by reducing complications and accelerating recovery.
Timestamp
00:00 The Impact of Mechanical Ventilation on Diaphragm Health
02:02 From R&D to COO: Viral Thakkar's Medtech Journey
03:20 A Journey from Personal Tragedy to Medical Device Innovation
05:56 Ventilator-Induced Diaphragm Dysfunction and Its Consequences
11:38 Innovative Diaphragm Stimulation Technology for Improved Ventilation
15:45 Breakthrough Medical Device Designation and Market Challenges
19:27 Innovative Ventilation Technology Aims to Improve ICU Patient Outcomes
Support the show

Follow or Connect with Rodney Moses:
Instagram | LinkedIn | YouTube |
Donations
Patreon | PayPal

  continue reading

64 episodes